Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis.

Epstein–Barr virus Fever of unknown origin HScore Hemophagocytic lymphohistiocytosis Hemophagocytosis

Journal

Memo
ISSN: 1865-5041
Titre abrégé: Memo
Pays: Austria
ID NLM: 101467972

Informations de publication

Date de publication:
2021
Historique:
received: 14 01 2021
accepted: 02 03 2021
pubmed: 8 4 2021
medline: 8 4 2021
entrez: 7 4 2021
Statut: ppublish

Résumé

HLH is a life-threatening disease, which is characterized by a dysregulated immune response with uncontrolled T cell and macrophage activation. The often fulminant course of the disease needs a fast diagnostic work-up to initiate as soon as possible the appropriate therapy. We present herein the case of a 71-year-old patient with rapidly progressive hyperinflammatory syndrome, which post mortem resulted in the diagnosis of EBV-associated HLH. With this case report, we intend to highlight the relevance of the HScore in the diagnosis of HLH, to create a greater awareness for EBV as a trigger of HLH, and to demonstrate the importance of treating EBV-associated HLH as early as possible.

Identifiants

pubmed: 33824685
doi: 10.1007/s12254-021-00701-9
pii: 701
pmc: PMC8015738
doi:

Types de publication

Journal Article

Langues

eng

Pagination

287-291

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Conflict of interestJ. Fauser, S. Köck, E. Gunsilius, A. Chott, A. Peer, A. Ditlbacher, G. Fritsche, M. Joannidis, D. Wolf, and A. Pircher declare that they have no competing interests.

Auteurs

Josia Fauser (J)

Department of Hematology and Oncology, Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Stefan Köck (S)

Department of Hematology and Oncology, Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Eberhard Gunsilius (E)

Department of Hematology and Oncology, Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Andreas Chott (A)

Institute of Pathology and Microbiology, Wilheminenspital, Vienna, Austria.

Andreas Peer (A)

Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Adelheid Ditlbacher (A)

Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Gernot Fritsche (G)

Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.

Michael Joannidis (M)

Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Dominik Wolf (D)

Department of Hematology and Oncology, Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Andreas Pircher (A)

Department of Hematology and Oncology, Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Classifications MeSH